~/blog/proprietary-blends-persist-testing-selling-point
Proprietary blends persist even as third-party testing becomes a selling point
More nootropics brands now advertise outside lab testing. A surprising number of those same labels still hide their doses inside a blend.
There is a contradiction sitting on a lot of shelves right now, and it is worth naming.
Third-party testing has become a marketing asset in nootropics. Brands that once said nothing about verification now put a laboratory’s name on the front of the tub. That is a genuine improvement, and we would rather have it than not.
The contradiction is that a meaningful share of those same products still list their active ingredients inside a proprietary blend — a single total weight covering several ingredients, with no individual doses disclosed.
Why the two do not sit together
A third-party test answers the question “is what the label claims actually in there?” A proprietary blend prevents the label from making a claim specific enough to test against.
If a panel says “Focus Blend — 1,200 mg” and lists five ingredients underneath in unspecified proportions, an outside laboratory can confirm those five substances are present and can quantify them. What it cannot do is tell you whether the result matches the label, because the label did not commit to anything. The verification is real; the thing being verified is a total.
That is not a fraud. It is a marketing structure that survives verification without being improved by it.
What is actually protected
The stated reason for blends is formulation secrecy — stopping competitors copying a ratio. The argument has always been thin, because analytical chemistry is not difficult and any competitor sufficiently motivated to copy a formula can simply have it analysed. The party that cannot easily do that is the buyer.
The practical effect is that the reader cannot check the one thing that determines whether a formula is likely to do anything: whether each ingredient is present at a dose resembling the studies the brand cites. An ingredient can be in a product at a fraction of a studied dose and still appear on the panel in bold.
What to look for instead
Full disclosure of per-ingredient doses, in milligrams, on the panel. It is not a high bar, and a growing number of brands clear it — often the same ones publishing test results, which suggests the two practices travel together when a company means them.
Where you see a blend, the useful question is not whether the brand is hiding something specific. It is simpler than that: without doses, neither you nor anyone else can evaluate the formula, and a product that cannot be evaluated should be priced accordingly.
These are supplements, not medicines. They are not evaluated by the FDA, they are not intended to diagnose, treat, cure or prevent any disease, and nothing here is medical advice.